Influence of Disease Duration on Circulating Levels of miRNAs in Children and Adolescents with New Onset Type 1 Diabetes

Keyphrases

• Circulating Levels 100%
• Disease Duration 100%
• MicroRNA 100%
• New-onset Type 1 Diabetes 100%
• Type I Diabetes 50%
• Type 1 Diabetes Mellitus (T1DM) 50%
• Circulating microRNA 50%
• Pancreatic Autoantibodies 50%
• Blood Samples 25%
• Quantitative PCR 25%
• Immune Response 25%
• Recent-onset 25%
• Interleukin-10 25%
• First Year 25%
• Signaling Pathway 25%
• Expression Level 25%
• Disease Progression 25%
• Interleukin-22 (IL-22) 25%
• Interleukin-4 (IL-4) 25%
• Repeated Measurements 25%
• IA-2A 25%
• Interleukin-21 (IL-21) 25%
• Path Analysis 25%
• MiRNA Expression Profile 25%
• Mixed Models 25%
• MiR-30a-5p 25%
• Immunological Processes 25%
• Immunological Pathways 25%
• Remission Phase 25%
• MiR-423 25%
• MiR-497-5p 25%
• MiR-99a 25%
• Hsa-miR-125b-5p 25%
• MiR-93-5p 25%
• Pancreatic Antibodies 25%
• MiR-17-5p 25%
• MiR-10b-5p 25%

Immunology and Microbiology

• Cytokine 100%
• Autoantibodies 66%
• Monospecific Antibody 33%
• Quantitative Reverse Transcription Polymerase Chain Reaction 33%
• Signal Transduction 33%